The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Tehrani, Fahimeh R ^a   Rashidi, Homeira ^b   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Idiopathic hirsutism (ih); Nih criteria; Polycystic ovary syndrome (pcos); Prevalence; Tehran lipid and glucose study (tlgs)

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERANDROGENISM; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OVARY POLYCYSTIC DISEASE; ADOLESCENT; BLOOD; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; HOSPITALIZATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; QUESTIONNAIRE;

PROGESTERONE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; IRAN; MASS SCREENING; MENSTRUATION DISTURBANCES; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PREVALENCE; PROGESTERONE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 81255205276     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-144     Document Type: Article

References (48)

1. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000, 21:347-362. 10.1210/er.21.4.347, 10950156.
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009, 91:456-488. 10.1016/j.fertnstert.2008.06.035, 18950759.
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85:2434-2438. 10.1210/jc.85.7.2434, 10902790.
4. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010, 25:544-551. 10.1093/humrep/dep399, 19910321.
5. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011, 9:39. 10.1186/1477-7827-9-39, 3070632, 21435276.
6. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004, 89:2745-2749. 10.1210/jc.2003-032046, 15181052.
7. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011, 62:238-242.
8. Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008, 139:59-64. 10.1016/j.ejogrb.2007.12.018, 18378061.
9. Goodarzi MO, Quinones MJ, Azziz R, Rotter JI, Hsueh WA, Yang H. Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril 2005, 84:766-769. 10.1016/j.fertnstert.2005.03.051, 16169421.
10. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078-3082. 10.1210/jc.83.9.3078, 9745406.
11. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999, 51:779-786.
12. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84:4006-4011. 10.1210/jc.84.11.4006, 10566641.
13. Farah L, Lazenby AJ, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med 1999, 44:870-874.
14. Moran C, Tena G, Moran S, Ruiz P, Reyna R, Duque X. Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol Obstet Invest 2010, 69:274-280. 10.1159/000277640, 20110726.
15. Ansarin H, Aziz-Jalali MH, Rasi A, Soltani-Arabshahi R. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women. Arch Iran Med 2007, 10:7-13.
16. Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 1998, 70:274-278. 10.1016/S0015-0282(98)00141-1, 9696220.
17. Barbieri RL. Hyperandrogenic disorders. Clin Obstet Gynecol 1990, 33:640-654. 10.1097/00003081-199009000-00028, 2225591.
18. Christakou CD, Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond Engl) 2008, 4:583-594.
19. Chun-Sen H, Chien-Hua W, Wan-Chun C, Ching-Tzu L, Chun-Jen C, Ming IH. Obesity and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2011, 5:300-306.
20. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004, 89:5454-5461. 10.1210/jc.2003-032237, 15531497.
21. Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG 2009, 116:1633-1639. 10.1111/j.1471-0528.2009.02347.x, 19781047.
22. El-Mazny A, Abou-Salem N, El-Sherbiny W. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynaecol Obstet 2010, 109:239-241. 10.1016/j.ijgo.2010.01.014, 20199774.
23. Abdel Fattah NS, Darwish YW. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?. Br J Dermatol 2009, 160:1011-1015. 10.1111/j.1365-2133.2009.09078.x, 19298279.
24. Norman RJ, Mahabeer S, Masters S. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril 1995, 63:58-62.
25. Dunaif A, Sorbara L, Delson R, Green G. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes 1993, 42:1462-1468. 10.2337/diabetes.42.10.1462, 8375585.
26. DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 2006, 91:1345-1350. 10.1210/jc.2004-2301, 16449347.
27. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 1991, 72:1242-1248. 10.1210/jcem-72-6-1242, 1827450.
28. Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol 2008, 168:321-328. 10.1093/aje/kwn137, 18550559.
29. Hsu MI, Liou TH, Chou SY, Chang CY, Hsu CS. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 2007, 88:727-729. 10.1016/j.fertnstert.2006.11.149, 17706215.
30. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981, 140:815-830.
31. Malcolm CE, Cumming DC. Does anovulation exist in eumenorrheic women?. Obstet Gynecol 2003, 102:317-318. 10.1016/S0029-7844(03)00527-1, 12907106.
32. Mehta A, Matwijiw I, Taylor PJ, Salamon EA, Kredentser JV, Faiman C. Should androgen levels be measured in hirsute women with normal menstrual cycles?. Int J Fertil 1992, 37:354-357.
33. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, Sarbazi N. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol 2003, 18:311-319.
34. Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968, 203:377-380. 10.1001/jama.203.6.377, 5694118.
35. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967, 12:77-126.
36. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online 2004, 8:644-648. 10.1016/S1472-6483(10)61644-6, 15169578.
37. Barth JH, Yasmin E, Balen AH. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol (Oxf) 2007, 67:811-815.
38. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006, 113:1210-1217. 10.1111/j.1471-0528.2006.01008.x, 16972863.
39. Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987, 1:235-245. 10.3109/09513598709023610, 3140583.
40. Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clin Endocrinol (Oxf) 2002, 57:343-350.
41. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol 1998, 139:421-423. 10.1530/eje.0.1390421, 9820619.
42. Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia-Hernandez E, Bermudez JA. Etiological review of hirsutism in 250 patients. Arch Med Res 1994, 25:311-314.
43. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006, 91:2-6. 10.1210/jc.2005-1457, 16981305.
44. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006, 91:781-785.
45. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata. Fertil Steril 2007, 87:1108-1115. 10.1016/j.fertnstert.2006.11.012, 1876794, 17241625.
46. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992, 57:505-513.
47. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004, 89:318-323. 10.1210/jc.2003-030932, 14715867.
48. Mohammad K, Sadat Hashemi SM, Farahani FK. Age at natural menopause in Iran. Maturitas 2004, 49:321-326. 10.1016/j.maturitas.2004.02.006, 15531128.